Although representing a minority of tumour cells, CD133+/CD44+ GSCs are the real cells that are responsible for GBM aggressiveness and infiltration, due to the activation of neoangiogenesis, resistance to therapies, and finally, the death of patients, as their complete surgical eradication is not possible without causing severe brain damage. This evidence concerns the gene PROM1 and glioblastoma.